卵巢Brenner瘤研究进展  

Research Progress of Ovarian Brenner Tumor

作　　者：万桃 俞萍源 邢义涓 王黎 杨永秀(审校)[2] WAN Tao;YU Ping-yuan;XING Yi-juan;WANG Li;YANG Yong-xiu(The First Clinical Medical College of Lanzhou University,Lanzhou 730000,China;Department of Obstetrics and Gynecology,The First Hospital of Lanzhou University,Key Laboratory of Gynecologic Oncology of Gansu Province,Lanzhou 730000,China)

机构地区：[1]兰州大学第一临床医学院,730000 [2]兰州大学第一医院妇产科,甘肃省妇科肿瘤重点实验室

出　　处：《国际妇产科学杂志》2023年第1期20-25,共6页Journal of International Obstetrics and Gynecology

基　　金：甘肃中医药管理项目(GZKG-2020-46);兰州大学第一医院院内基金(LDYYLL2022-87)。

摘　　要：卵巢Brenner瘤是卵巢肿瘤的罕见病理类型,可分为良性、交界性/非典型增殖性及恶性。其病因及发病机制尚不明确,临床表现及影像学检查无特异性,术前易误诊,确诊主要依靠术后病理学检查。近年研究发现卵巢恶性Brenner瘤(malignant Brenner tumor,MBT)由卵巢良性Brenner瘤逐渐进展而来,且发生过程与成纤维细胞生长因子受体3(fibroblast growth factor receptor 3,FGFR3)、CCND1、鼠双微体基因2(murine double minute 2,MDM2)、细胞周期蛋白依赖性激酶抑制因子2A(cyclin-dependent kinase inhibitor 2A,CDKN2A)及磷脂酰肌醇3激酶催化亚基ɑ(phosphoinositide 3-kinase catalytic alpha polypeptide,PIK3CA)等基因变异有关。卵巢Brenner瘤的治疗以手术为主,其中卵巢MBT术后可辅以铂类-紫杉醇方案化疗,并有望针对其致癌位点进行靶向治疗,而分期是重要的预后因素,早诊断、早治疗是改善预后的关键。Ovarian Brenner tumor is a rare pathological type of ovarian tumor,which can be divided into benign,borderline/atypical proliferalive and malignant.Its etiology and pathogenesis are still unclear,the clinical manifestations and imaging examinations are not specific,and it is easy to misdiagnose before surgery,and the diagnosis mainly depends on postoperative pathological examination.Recent studies have found that malignant Brenner tumor(MBT)gradually progresses from benign Brenner tumor of the ovaries,and the process of occurrence is related to the genetic variants of fibroblast growth factor receptor 3(FGFR3)gene,CCND1 gene,and murine double microbody gene 2(MDM2),cyclin-dependent kinase inhibitor 2A(CDKN2A)gene and phosphoinositide 3-kinase catalytic alpha polypeptide(PIK3CA)gene.The treatment of ovarian Brenner tumor is mainly surgery,in which ovarian MBT can be supplemented with platinum-paclitaxel chemotherapy after surgery,and it is expected to be targeted therapy for its carcinogenic sites.Staging is an important prognostic factor,and early diagnosis and treatment is the key to improve prognosis.

关 键 词：卵巢肿瘤 BRENNER瘤 基因 突变 诊断 治疗 

分 类 号：R737.31[医药卫生—肿瘤]